PO-1373 Targeted biopsies are redundant in mp-MRI and PSMA-PET proven radiorecurrent prostate cancer.

Saved in:
Bibliographic Details
Title: PO-1373 Targeted biopsies are redundant in mp-MRI and PSMA-PET proven radiorecurrent prostate cancer.
Authors: Peters, M. (AUTHOR), van Son, M. (AUTHOR), Rasing, M. (AUTHOR), Lagendijk, J. (AUTHOR), Moerland, M. (AUTHOR), van de Pol, S. (AUTHOR), Eppinga, W. (AUTHOR), Jonges, T. (AUTHOR), Wessels, F. (AUTHOR), de Keizer, B. (AUTHOR), Noteboom, J. (AUTHOR), van der Voort van Zyp, J. (AUTHOR)
Source: Radiotherapy & Oncology. 2021 Supplement 1, Vol. 161, pS1124-S1125. 2p.
Subjects: Biopsy, Prostate cancer
Database: Engineering Source
Description
ISSN:01678140
DOI:10.1016/S0167-8140(21)07824-5